Qtron Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,815
| Closed | -$388K | – | 463 |
|
|
2024
Q2 | $388K | Hold |
2,815
| – | – | 0.06% | 356 |
|
|
2024
Q1 | $388K | Sell |
2,815
-1,256
| -31% | -$173K | 0.06% | 391 |
|
|
2023
Q4 | $536K | Hold |
4,071
| – | – | 0.09% | 314 |
|
|
2023
Q3 | $458K | Sell |
4,071
-660
| -14% | -$74.3K | 0.09% | 305 |
|
|
2023
Q2 | $446K | Hold |
4,731
| – | – | 0.08% | 298 |
|
|
2023
Q1 | $479K | Hold |
4,731
| – | – | 0.1% | 279 |
|
|
2022
Q4 | $565K | Buy |
4,731
+2,815
| +147% | +$336K | 0.12% | 240 |
|
|
2022
Q3 | $203K | Buy |
+1,916
| New | +$203K | 0.05% | 394 |
|